In a saga that dates back to before Christmas I still do not have a home phototherapy unit. Sadly, documenting the insurance denials from Western Health Advantage (WHA), made no inroads with them. They denied coverage, my dermatologist and I appealed, and they denied the appeal of the denial. Simple. The next step to procure a home phototherapy unit would need to bypass insurance coverage.
I am getting tired and frustrated with my health insurance provider. Really. On December 15, 2017 my dermatologist, Dr. Maverakis, prescribed a home narrowband Uphototherapy unit. This unit, costing about five-thousand dollars, would treat both my psoriasis and atopic dermatitis (eczema). But about 100 days later insurance says no. Again.
I looked forward to my first dermatology appointment at 1:30 p.m. I drove into town around 12:30 to give myself plenty of time. Then it dawned on me. My dermatology appointment was at 11:30 a.m., not 1:30 p.m. Thankfully, the clinic staff showed kindness and allowed me to still see the new dermatologist and get the treatment I sought.
Two steps forward, and one step back. This old saying aptly describes how I feel about my experience with Tremfya (guselkumab) after ten weeks. Overall I see progress. But during these seventy days I can point to a few setbacks. I see my dermatologist for the last time this week to discuss my situation and say goodbyes.
When I started taking Tremfya (guselkumab), I carried an unstated goal and expectation: clear skin. I looked at the graphs and incredible data on the effectiveness of Tremfya and just figured I could enjoy life with less and less psoriasis over the course of sixteen weeks. At six weeks, some forty-two days later, I’m readjusting my expectations.